Compare GLPI & MEDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GLPI | MEDP |
|---|---|---|
| Founded | 2013 | 1992 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.6B | 13.4B |
| IPO Year | N/A | 2016 |
| Metric | GLPI | MEDP |
|---|---|---|
| Price | $41.95 | $543.83 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 12 | 12 |
| Target Price | $51.88 | ★ $465.18 |
| AVG Volume (30 Days) | ★ 2.4M | 277.0K |
| Earning Date | 10-30-2025 | 10-22-2025 |
| Dividend Yield | ★ 7.45% | N/A |
| EPS Growth | N/A | ★ 25.36 |
| EPS | 2.79 | ★ 14.32 |
| Revenue | $1,577,336,000.00 | ★ $2,358,373,000.00 |
| Revenue This Year | $5.71 | $21.48 |
| Revenue Next Year | $4.63 | $11.90 |
| P/E Ratio | ★ $15.02 | $38.28 |
| Revenue Growth | 4.39 | ★ 13.88 |
| 52 Week Low | $41.78 | $250.05 |
| 52 Week High | $52.25 | $626.26 |
| Indicator | GLPI | MEDP |
|---|---|---|
| Relative Strength Index (RSI) | 32.51 | 36.48 |
| Support Level | $42.99 | $530.96 |
| Resistance Level | $43.90 | $626.26 |
| Average True Range (ATR) | 0.71 | 18.24 |
| MACD | -0.07 | -8.14 |
| Stochastic Oscillator | 3.72 | 17.60 |
Gaming and Leisure Properties Inc, or GLP, is a self-administered and self-managed Pennsylvania real estate investment trust (REIT). It is engaged in acquiring, financing, and owning real estate property to be leased to gaming operators in triple-net lease arrangements. Its portfolio consists of gaming and related facilities and amenities such as Ameristar Black Hawk, Bally's Casino, Argosy Casino Alton, Bally's Chicago, Hollywood Casino Aurora, and others located across different states in the United States.
Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical device firms. It also offers ancillary services, including bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has more than 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati, Ohio, and its operations are primarily based in the US, with additional presence in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.